chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report has been received from an unspecified person via social media referring to unspecified number of patients. On unknown date the patients were vaccinated with M-M-R II (dose, frequency, route and lot# not reported). It was reported that if CDC authors had published the truth in 2004, if they hadn't cooked the books, if they hadn't thrown away vital documents in the garbage, everybody would now know the M-M-R II had a connection to causing autism. The outcome of autism was unknown. Additional information is not expected.
This case was reported by a nurse and described an adult female subject who was vaccinated with hepatitis B vaccine recombinant Engerix B and subsequently tested positive for the hepatitis B antigen. Medical history included renal failure (cause not specified) requiring hemodialysis. The nurse reported that, on June 20 2005, a hepatitis B antigen test was negative. On 7/1/2005 the subject received the 1st dose of Engerix B. The nurse reported that, on 7/4/2005, 3 days after vaccination with Engerix, the patient was again tested for hepatitis B antigen and was found to be positive. The outcome for the event was not reported. The nurse considered the event to probably be related to vaccination with Engerix B.
Localized erythema/swelling with itching.  Advised benadryl and cool compresses for tx.
Rose thorn injury developed nodule in right 4th finger (R) hand that was a month & 1/2 before going to ER for tetanus shot, within 2 weeks of vaccination began having bilateral pain, more focused in (L) breast. L breast had an fined needle aspiration biopsy 5 years prior. There were multiple cysts in the left breast....There had been pain in the left breast following FNA-Fined Needle Aspiration, finally subsided completely until receiving the ADACEL within 2 weeks began having bilateral pain and that continued since. So I was given Intraconazole on 10/16/2010- I took 3 doses then stopped. In addition to the breast pain which is at the sites of the cyst the breast. There has also been an exacerbation of the supra clavicular lymph node pain extending to the left shoulder - bilateral pain, primarily on the left side. There is no fever, taking no hormones, post-menopausal. At this time there is no diagnose that suggest a cause other than the administration of the ADACEL which was the DTAP with the exception of the needle track pain from the FNA 5 years prior the breast had been asymptomatic until the administration of the ADACEL.
Patient describes pain in the arm over a month after receiving the vaccine. Described as muscular pain that runs up and down the arm. Started about 24 hours after receiving booster dose and has not subsided.
Severe periorbital edema, pruritis, mild facial edema.  Onset approximately 15 hours after vaccination.  Patient instructed by provider to take Benadryl 25mg every 6 hours as needed.  Symptoms subsiding.
Starting Friday June 10th I began noticing cold symptoms, nasal and head congestion, some fatigue. No fever.  This peaked around June 13-15 and declined over the next week, fully resolved by about June 24.
Information has been received from a physician for the pregnancy registry for GARDASIL concerning a 24 year old female with no known allergies who on 18-SEP-2007 was vaccinated IM with her first dose of GARDASIL (Lot # 658560/1062U). concomitant therapy included (ASTELIN) and Albuterol. Subsequently the patient is pregnant which was confirmed via pregnancy test (LMP = 28-AUG-2007). No further information is available. Follow up information was received from a nurse who reported that on 12-JUN-2008, the patient went into labor spontaneously at 41+ 3/7 weeks with SROM with a moderate amount of meconium in the amniotic fluid. The patient had a vaginally delivered at a healthy female. The baby weight was 8 Lb, 7 oz, and had apgars of 9 and 9. The nurse reported that the patient's EDD was on 03-JUN-2007. The nurse also reported that the baby and the mother were doing well. No further information is expected.
Cold sore on left corner of mouth, resolved in 1 day with Abreva & Valtrex; mild dizziness for about an hour, injection site tenderness resolved in 1 day
felt a little tired afterwards; chills; bad headache; ached all over; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 15Feb2021 (Lot number: EL9262) at the age of 65 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Single, Lot: EL3246, Site: left arm), administration date: 25Jan2021, when the patient was 65 years old, for Covid-19 Immunization. The following information was reported: CHILLS (non-serious) with onset 15Feb2021, outcome "recovered" (15Feb2021), described as "chills"; HEADACHE (non-serious) with onset 15Feb2021, outcome "recovered" (15Feb2021), described as "bad headache"; PAIN (non-serious) with onset 15Feb2021, outcome "recovered" (16Feb2021), described as "ached all over"; FATIGUE (non-serious) with onset 16Feb2021, outcome "unknown", described as "felt a little tired afterwards".  Additional information: The reporter stated when she got the second shot, she had a slight reaction, including chills, bad headache for 2 hours, and ached all over. The next day she felt fine, just a little tired. No investigation assessment was reported.  No follow-up attempts are possible. No further information is expected.
Dizziness and light-headedness 2-3 hours post-vaccination. Nausea by 12/18 AM, vomited X 3. Contacted PCP by phone and was advised to call health dep't.
Experienced mild soreness in arm after each injection; This is a spontaneous report from a contactable physician. This physician (patient) with unknown age and gender reported that he received the first and second dose (21 days apart) of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route at arm (deltoid) on an unknown dates at single dose for COVID-19 immunization. Medical history and concomitant drugs were not reported. Patient experienced mild soreness in arm after each injection on an unknown date. Outcome of event was unknown.  Information on the lot/batch number has been requested.
About 4 weeks after receiving the booster shot, my OBGYN noticed a lump in my neck that was a cystic thyroid nodule. There is no family history of thyroid issues. An ultrasound and biopsy of the nodule were completed in December 2021 and January 2022. The nodule made it difficult to breathe and was moveable. I made an appointment with my ENT on February 18, and he decided the best route to go was to remove the nodule and the right lobe of the thyroid. The thyroid was removed on March 16, 2022.
Patient drove himself from the health department to the pharmacy for his typhoid prescription and to the barbershop for a haircut.  He began coughing, developed a rash and itching.  Took a shower when he got home.  Symptoms persisted.  Mom took him to the emergency room, medication prescribed.
Pt. presented w/ large hot red area 3" x 4" on Bicep   s/w pt this am (10/15) swelling seems to be subsiding
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2012, the patient was inoculated with the ZOSTAVAX vaccine at a medical center as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. In 2013, the patient was treated at urgent care center for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster, or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
can feel lump in rt upper thigh under site of shot;advised to use APAP if discomfort;
sore arm; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (tired) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (tired). At the time of the report, PAIN IN EXTREMITY (sore arm) and FATIGUE (tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       patient relaxed all day and took it easy and drunk plenty of water. No relevant concomitant product were reported No treatment medication was provided   This case was linked to MOD-2022-442240, MOD-2022-442243 (Patient Link).
Within 1-2 minutes of administration, patient became diaphoretic and complained of nausea. Patient examined by on-site provider, vital signs remained stable throughout. Patient was transported by EMS to emergency room for further evaluation.
It took about 2.5 weeks for non-conclusive pulmonary embolisms to appear in both the right and left lungs
prolonged, inconsolable, high pitched crying for more than 3 hrs, took to ER, no treatment; mom reported @ time of next scheduled vax;
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 69-year-old male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced pain in arm and erythema of extremities. On an unknown date, the outcome of the pain in arm was recovered/resolved and the outcome of the erythema of extremities was unknown. It was unknown if the reporter considered the pain in arm and erythema of extremities to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient called to the GlaxoSmithKline Response Center (GRC) about the availability of a SHINGRIX vaccine and reported that first shot of SHINGRIX was resulted in his arm aching so badly. The arm that received the shot had redness. The pain lasted for over 48 hours. The patient gave consent to follow up.
Yeast infection of the mouth; Gum bleeding; Throat discomfort; Feeling abnormal; Mouth pain; Feeling strange; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GINGIVAL BLEEDING (Gum bleeding), OROPHARYNGEAL DISCOMFORT (Throat discomfort), FEELING ABNORMAL (Feeling abnormal), ORAL PAIN (Mouth pain ) and FEELING ABNORMAL (Feeling strange) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Tonsillectomy. Concomitant products included LEVONORGESTREL (MIRENA), FEXOFENADINE HYDROCHLORIDE (ALLEGRA), MONTELUKAST SODIUM (SINGULAIR) and DESVENLAFAXINE SUCCINATE (PRISTIQ) for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced GINGIVAL BLEEDING (Gum bleeding), OROPHARYNGEAL DISCOMFORT (Throat discomfort), FEELING ABNORMAL (Feeling abnormal), ORAL PAIN (Mouth pain ) and FEELING ABNORMAL (Feeling strange). On an unknown date, the patient experienced ORAL FUNGAL INFECTION (Yeast infection of the mouth). The patient was treated with FLUCONAZOLE (DIFLUCAN) for Yeast infection of the mouth, at a dose of 1 dosage form. On 26-Mar-2021, GINGIVAL BLEEDING (Gum bleeding) had resolved. At the time of the report, OROPHARYNGEAL DISCOMFORT (Throat discomfort), FEELING ABNORMAL (Feeling abnormal), ORAL PAIN (Mouth pain ), FEELING ABNORMAL (Feeling strange) and ORAL FUNGAL INFECTION (Yeast infection of the mouth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included gargle salt water.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: significant follow-up received on 19-Apr-2021, appended in the case on 27-Apr-2021.Event reported by the reporter with Diflucan treatment information.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Fever, chills, nausea, headache, fatigue, and body cramps.
Her lungs hurt to inhale and exhale for a couple of days; The left upper eyelid swell up slightly; Is very irritated; Is very itchy; Muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Her lungs hurt to inhale and exhale for a couple of days), SWELLING OF EYELID (The left upper eyelid swell up slightly), EYE IRRITATION (Is very irritated), EYE PRURITUS (Is very itchy) and MYALGIA (Muscle pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included AMLODIPINE, CHROMIC CHLORIDE, CINNAMOMUM SPP., GYMNEMA SYLVESTRE, THIOCTIC ACID (DIABETES), VITAMIN D;VITAMIN E and BIOTIN for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Her lungs hurt to inhale and exhale for a couple of days), SWELLING OF EYELID (The left upper eyelid swell up slightly), EYE IRRITATION (Is very irritated), EYE PRURITUS (Is very itchy), MYALGIA (Muscle pain) and HEADACHE (Headache). At the time of the report, DYSPNOEA (Her lungs hurt to inhale and exhale for a couple of days) had resolved and SWELLING OF EYELID (The left upper eyelid swell up slightly), EYE IRRITATION (Is very irritated), EYE PRURITUS (Is very itchy), MYALGIA (Muscle pain) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.
Feeling faint, cough, broke out in rash everywhere numbness and tingling in mouth, lips, teeth, tongue, head, arms fingers, legs and feet. Headache, tired, very irritable and angry.
A few clinic employees failed to sero-convert p/recvd 3 doses of Engerix-B;
Patient was fully vaccinated after receiving her 2nd COVID vaccine on 3/6/21.  She had received her 1st Moderna vaccine on 2/6/21.  Patient tested positive for COVID on 8/2/21 at her primary care MD's office.
More rapid heart beat; Legs hurt; Muscles hurt; Tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED (More rapid heart beat), PAIN IN EXTREMITY (Legs hurt), MYALGIA (Muscles hurt) and FATIGUE (Tired) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included Surgery (Pace maker surgery reported in the medical history).    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PAIN IN EXTREMITY (Legs hurt), MYALGIA (Muscles hurt) and FATIGUE (Tired). On 17-Feb-2021, the patient experienced HEART RATE INCREASED (More rapid heart beat). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEART RATE INCREASED (More rapid heart beat), PAIN IN EXTREMITY (Legs hurt), MYALGIA (Muscles hurt) and FATIGUE (Tired) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Diagnosed with Covid 19 in august 2021. I had fever, cough, muscle and joint pain, cough, and shortness of breath. Edd 10/20/2021 baby born by induction on 10/19/2022 birth weight 7lbs 9oz
Initial unsolicited report received from a nurse on 18-Oct-2017. This case involves an eight-year-old female patient, who was vaccinated once with FLUZONE QUADRIVALENT via intramuscular route (batch number: U5913BA, expiry date: 30-Jun-2018; dose not reported) in right arm on 10-Oct-2017. Patient's medical history and concomitant medications were not reported. It was reported that no other immunizations received at that time. On an unknown date, approximately 18-20 hours following vaccination, the patient developed rash with hives approximately. Patient stated rash was extremely itchy. On 18-Oct-2018, patient was seen by physician (doctor visit), rash with hives continued. Lab test and not reported. As corrective treatment, patient was prescribed with HYDROCORTISONE 2.5%, PREDNISONE 10mg one time dose and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL) 25mg as needed. Patient had not recovered from the events. Upon internal review the case was considered as serious due to important medical event: urticarial rash and itchy rash. Documents held by sender: none.; Sender's Comments: The patient developed rash with hives approximately 18-20 hours following vaccination, the rash was extremely itchy post vaccination with FLUZONE QUADRIVALENT Time to onset was compatible and suggestive of a possible anaphylactic/allergic reaction. Patient's medical history was not reported. Additional information regarding patient's allergic history or reaction to previous medications should be requested along with information regarding patient's medical condition at the time of vaccination. Based upon reported information this looks like a case of allergic response and role of the vaccine cannot be assessed until further information is received.
Received vaccine at 10:44am. My arm was a little sore almost immediately. Approximately 12:30-1:00pm, I started getting a bit nauseated, pit in my stomach . Lasted until went to bed around 9:00pm. In morning felt fine except my arm felt much more sore at the shot point for about 2-3 hours after I woke up.  10:00am everything is normal.
tinnitus.; This is spontaneous report from a contactable physician (the patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported) via an unspecified route of administration on 12Apr2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Approximately 9-10 days after the vaccine caller experienced tinnitus (Apr2021). The outcome of the event was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Information has been received from a healthcare worker referring to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, concomitant medication and medical history were not provided. On unspecified dates, the patients were vaccinated with (Merck) VARIVAX (lot # L012038, expiration date 07-APR-2017) (lot # was reported as L021215, expiration date 10-JUN-2017) (dose, route and dose number were unspecified). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Woke up with a severe headache, threw up, had chil. A rash on my neck developed that was red, itchy, and scaly and has persisted for 4 days.
Within about an hour after receiving the MMR vaccine my son said that he didn't feel right. He said that something felt really wrong. He suddenly became extremely fatigued and then he began to start crying out of control and act really out of character. He kept repeating that something was not right and that something was seriously wrong. He was very upset and agitated. These symptoms continued for about 4 months to five months everyday following the vaccine. During that time, he was extremely fatigued to the point that he didn't even have the energy to even play. I was very concerned as a parent and contribute it to the vaccine. I am not sure whether or not he has fully recovered from this incident. He has developed sensory integration and dyspraxias.
pt received vaccine without incident and was then directed to observation area  in approximately 5 minutes pt reportedly told companion he was not feeling well.  He then quickly slumped over and lost consciousness.  Pt was lowered to the floor, legs elevated and rescue called.  Pt almost immediately regained consciousness and reported he felt fine.  Rescue arrived and had pt sit in a chair.  They checked his vitals and he refused transport.  Pt left with his companion.
This solicited report has been received from an unspecified reporter. This report refers to a 11 year old female patient, enrolled in a market research. No information on patient's medical history, concurrent conditions and concomitant medications was provided. On an unknown date, the patient was vaccinated with the first dose of GARDASIL (strength, dose, indication, lot# and expiration date were not reported). On an unknown day in May 2016, the patient experienced injection site pain. It was reported that the patient received multiple unspecified vaccines that day. The outcome of the event was reported as recovered 3 days after injection. The action taken with GARDASIL was reported as none. The reporter considered injection site pain to be related to GARDASIL. Additional information has been requested.
Sweating, heart palpitations, shaky, dizzy, stomach cramping, numbness in injection arm, feeling of exhaustion, numbness periodically in face, especially around eyes and lips.
Generalized rash, papular, over face, trunk, arms. Complaints of mild sore throat 24 hours prior to rash. Mild headache. Treated with Tylenol, Aveeno Bath.
pt recvd vax 3FEB93 & 24 hrs following vax pt devel a t014; No further details were provided;